Laura Borodyansky
- Co-authors
- Johannes FruehaufAmy E. ParkerShuanglin XiangArthur B. PardeeLili HuangChiang J. LiBin ShiYutaka Ueda
- Topics
- Bioactive Compounds and Antitumor Agents (12 papers)Cancer Cells and Metastasis (10 papers)Cancer Mechanisms and Therapy (6 papers)
- Cited by
- ToxicologyVirologyOncology
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical OncologyBritish Journal of Cancer
- Partner nations
- United StatesJapanCanada
In The Last Decade
Laura Borodyansky
27 papers receiving 459 citations
Peers
Comparison fields: 5 of 60
- Molecular Biology 267
- Oncology 172
- Immunology 84
- Virology 79
- Cancer Research 72
Countries citing papers authored by Laura Borodyansky
This map shows the geographic impact of Laura Borodyansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Borodyansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Borodyansky more than expected).
Fields of papers citing papers by Laura Borodyansky
This network shows the impact of papers produced by Laura Borodyansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Borodyansky. The network helps show where Laura Borodyansky may publish in the future.
Co-authorship network of co-authors of Laura Borodyansky
This figure shows the co-authorship network connecting the top 25 collaborators of Laura Borodyansky. A scholar is included among the top collaborators of Laura Borodyansky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Borodyansky. Laura Borodyansky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 20 | |
| 3 | 16 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 11 | |
| 8 | 16 | |
| 9 | 12 | |
| 10 | 7 | |
| 11 | 11 | |
| 12 | 5 | |
| 13 | 6 | |
| 14 | 3 | |
| 15 | 0 | |
| 16 | 35 | |
| 17 | 137 | |
| 18 | 11 | |
| 19 | 3 | |
| 20 | 98 |
About Laura Borodyansky
Laura Borodyansky is a scholar working on Toxicology, Applied Microbiology and Biotechnology and Oncology, having authored 28 papers that have together received 470 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (12 papers), Cancer Cells and Metastasis (10 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Toxicology (62 citations), Virology (79 citations) and Oncology (172 citations). Laura Borodyansky has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Johannes Fruehauf, Amy E. Parker, Shuanglin Xiang, Arthur B. Pardee, Lili Huang, Chiang J. Li, Bin Shi, Yutaka Ueda, Youzhi Li and Chiang Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.